Recent advances in drug repurposing using machine learning

Drug repurposing aims to find new uses for already existing and approved drugs. We now provide a brief overview of recent developments in drug repurposing using machine learning alongside other computational approaches for comparison. We also highlight several applications for cancer using kinase in...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Current opinion in chemical biology Ročník 65; s. 74 - 84
Hlavní autori: Urbina, Fabio, Puhl, Ana C., Ekins, Sean
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Elsevier Ltd 01.12.2021
Predmet:
ISSN:1367-5931, 1879-0402, 1879-0402
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Drug repurposing aims to find new uses for already existing and approved drugs. We now provide a brief overview of recent developments in drug repurposing using machine learning alongside other computational approaches for comparison. We also highlight several applications for cancer using kinase inhibitors, Alzheimer’s disease as well as COVID-19. [Display omitted] •Machine learning for drug repurposing was increasing before 2020.•It has been applied to model small molecule screening data, transcriptomics and proteomics.•Computationally repurposed approved kinase inhibitors have been identified by several groups.•Computational repurposing can be used in areas of difficult drug discovery e.g. antibiotics and Alzheimer 's disease.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1367-5931
1879-0402
1879-0402
DOI:10.1016/j.cbpa.2021.06.001